Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290196 · ClinicalTrials.gov registry record · Phase 4
The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics
A Phase 4 study, sponsored by Andrews Research & Education Foundation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT03290196 is a Phase 4 study that was terminated before completion, run by Andrews Research & Education Foundation. The registered enrollment target is 13 participants.
The verdict
NCT03290196, a Phase 4 study, was terminated before completion, sponsored by Andrews Research & Education Foundation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
Patients undergoing shoulder rotator cuff surgery in an outpatient setting are the focus of this study. The purpose of this study is to determine if the product EXPAREL® can be used as a safe alternative in shoulder surgery to pain pumps, while limiting narcotic use and providing appropriate postoperative pain control.
Interventions
- DRUG EXPAREL 1.3 % in 20 ML Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-09-03 |
| Est. Completion | 2022-04-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03290196
The ClinicalTrials.gov registry entry for NCT03290196 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrews Research & Education Foundation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EXPAREL 1.3 % in 20 ML Injection is the first listed.
NCT03290196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03290196 about?
NCT03290196 is a clinical study titled "The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics". Patients undergoing shoulder rotator cuff surgery in an outpatient setting are the focus of this study. The purpose of this study is to determine if the product EXPAREL® can be used as a safe alternative in shoulder surgery to pain pumps, while limiting narcotic use and providing appropriate postope...
What is the current status of trial NCT03290196?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2015-09-03. Estimated completion is 2022-04-07.
What interventions are being tested in trial NCT03290196?
The interventions under investigation include: EXPAREL 1.3 % in 20 ML Injection (DRUG).
Who is sponsoring clinical trial NCT03290196?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.